Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Eledon Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +3 vs. Q1 2023
- Shares held
- 9.28M
- +3.03M (+48.6%) vs. Q1 2023
- Total value
- $12.7M
- −$2.02M (−13.7%) vs. Q1 2023
- New holders
- 6
- 10 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 4,326,710 | $5.93M | 0.17% | +2,000,000+86.0% | Added |
| Armistice Capital, LLC | 1,842,803 | $2.52M | 0.06% | +1,842,803 | New |
| Vanguard Group Inc | 679,557 | $931.0K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 516,675 | $707.8K | 0.01% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 443,001 | $606.9K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 273,345 | $374.0K | 0.00% | +273,345 | New |
| CM Management, LLC | 234,803 | $322.0K | 0.31% | +30.0% | Added |
| Ikarian Capital, LLC | 221,830 | $303.9K | 0.11% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 169,650 | $232.4K | 0.00% | +40,499+31.4% | Added |
| Jmac Enterprises LLC | 80,041 | $109.7K | 0.03% | +25,503+46.8% | Added |
| Renaissance Technologies LLC | 60,373 | $83.0K | 0.00% | +28,200+87.7% | Added |
| Ingalls & Snyder LLC | 50,849 | $70.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 50,502 | $69.2K | 0.00% | +50,502 | New |
| State Street Corp | 44,692 | $61.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 43,002 | $58.9K | 0.00% | +30,397+241.2% | Added |
| Northern Trust Corp | 30,053 | $41.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 28,302 | $38.8K | 0.00% | −24,266−46.2% | Reduced |
| Two Sigma Advisers, LP | 23,000 | $31.5K | 0.00% | −2,100−8.4% | Reduced |
| Boothbay Fund Management, LLC | 22,050 | $30.2K | 0.00% | 00.0% | Unchanged |
| SVB Financial Group | 18,025 | $24.7K | 0.05% | −8,917−33.1% | Reduced |
| Virtu Financial LLC | 17,675 | $24.0K | 0.00% | +17,675 | New |
| Mercer Global Advisors Inc | 16,726 | $23.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,783 | $21.6K | 0.00% | +15,783 | New |
| Charles Schwab Investment Management Inc | 14,987 | $20.5K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 13,029 | $17.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,450 | $15.7K | 0.00% | +5,199+83.2% | Added |
| Two Sigma Investments, LP | 10,586 | $14.5K | 0.00% | −7,000−39.8% | Reduced |
| Citadel Advisors LLC | 7,740 | $10.6K | 0.00% | −23,070−74.9% | Reduced |
| Group One Trading, L.P. | 5,918 | $8.11K | 0.00% | +5,318+886.3% | Added |
| Morgan Stanley | 2,155 | $2.95K | 0.00% | +2,155 | New |
| Wells Fargo & Company | 146 | $200 | 0.00% | +60+69.8% | Added |
| UBS Group AG | 32 | $44 | 0.00% | −424−93.0% | Reduced |
| Simplex Trading, LLC | 220 | $0 | 0.00% | +151+218.8% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,217,882−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −17,954−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |